Triptolide inhibits ovarian cancer growth and metastasis via reprogramming of tumor-associated macrophages
Our findings indicate that the suppression of ovarian cancer by Triptolide is mediated in part through its capacity to reprogram TAMs via the Nrf2 pathway.